Pancreatic Cancer Clinical Trials in Chicago

Showing 81-100 of 150 trials

Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials

NCT02020252

The purpose of this research study is to test a touchscreen computer program, which allows patients to see information on a computer screen regarding cancer care, and specifically clinical trials. The purpose of this research is to help the investigators learn more about how to use technology in the medical setting to improve health outcomes.

Lung CancerGastric CancerPancreatic Cancer

University of Chicago120 participantsStarted Nov 2013

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

Vaccine Study for Surgically Resected Pancreatic Cancer

NCT00569387

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.

Pancreatic Cancer

NewLink Genetics Corporation73 participantsStarted Dec 2007

Scottsdale, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +15 more locations

Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials

Vaccine Study for Surgically Resected Pancreatic Cancer

Pancreatic Cancer Trials in Other Cities

Vaccine Treatment for Surgically Resected Pancreatic Cancer

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer

AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

Other Conditions in Chicago